Lipoprotein(a), Peripheral Artery Disease, and Abdominal Aortic Aneurysm: The Next Frontier or Another Risk Enhancer?
- PMID: 38057069
- DOI: 10.1016/j.jacc.2023.10.015
Lipoprotein(a), Peripheral Artery Disease, and Abdominal Aortic Aneurysm: The Next Frontier or Another Risk Enhancer?
Keywords: abdominal aortic aneurysm; lipoprotein(a); lower extremity amputation; major adverse limb events; peripheral artery disease.
Conflict of interest statement
Funding Support and Author Disclosures Dr Beckman has received research support from Bristol Myers Squibb; and has received consulting fees from Janssen, JanOne, and Novartis. Dr Sullivan is supported by the National Institutes of Health/National Institute of General Medical Science under award number T32 GM007569.
Comment on
-
Lipoprotein(a) and Risks of Peripheral Artery Disease, Abdominal Aortic Aneurysm, and Major Adverse Limb Events.J Am Coll Cardiol. 2023 Dec 12;82(24):2265-2276. doi: 10.1016/j.jacc.2023.10.009. J Am Coll Cardiol. 2023. PMID: 38057068
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical